SERANA, Federico
 Distribuzione geografica
Continente #
NA - Nord America 1.496
EU - Europa 728
AS - Asia 319
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.549
Nazione #
US - Stati Uniti d'America 1.489
PL - Polonia 318
CN - Cina 205
UA - Ucraina 167
DE - Germania 89
HK - Hong Kong 51
FI - Finlandia 47
SG - Singapore 38
IT - Italia 30
IE - Irlanda 28
FR - Francia 16
VN - Vietnam 12
GB - Regno Unito 11
SE - Svezia 10
BE - Belgio 8
CA - Canada 7
IN - India 6
TR - Turchia 3
AU - Australia 2
CZ - Repubblica Ceca 2
EU - Europa 2
AR - Argentina 1
BD - Bangladesh 1
CK - Cook, isole 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
RU - Federazione Russa 1
Totale 2.549
Città #
Warsaw 318
Fairfield 218
Woodbridge 152
Jacksonville 125
Chandler 101
Houston 101
Ann Arbor 99
Ashburn 98
Cambridge 94
Seattle 84
Dearborn 71
Wilmington 65
Princeton 53
Hong Kong 50
Nanjing 44
Beijing 31
Helsinki 31
Dublin 28
New York 28
Shanghai 19
Nanchang 16
Singapore 16
Des Moines 15
San Diego 15
Shenyang 14
Boardman 12
Dong Ket 12
Hebei 12
Tianjin 11
Jinan 10
Brussels 8
Kunming 8
Brescia 7
Changsha 5
San Francisco 5
Toronto 5
Jiaxing 4
Milan 4
Norwalk 4
Phoenix 4
Zhengzhou 4
Indiana 3
Leawood 3
Ningbo 3
Brno 2
Guangzhou 2
Gunzenhausen 2
Hangzhou 2
Hefei 2
Indianapolis 2
London 2
Montréal 2
Munich 2
Prad am Stilfser Joch 2
Pune 2
Taizhou 2
Wuhan 2
Amman 1
Athens 1
Brooklyn 1
Buenos Aires 1
Canberra 1
Castel Mella 1
Central 1
Chicago 1
Chongqing 1
Dhaka 1
Falkenstein 1
Formello 1
Frankfurt am Main 1
Fuzhou 1
Gorle 1
Haifa 1
Haikou 1
Hounslow 1
Hyderabad 1
Kocaeli 1
Lancaster 1
Lanzhou 1
Los Angeles 1
Melbourne 1
Monmouth Junction 1
Putignano 1
Southwark 1
Surbo 1
Trieste 1
Verona 1
Vientiane 1
Walnut 1
Washington 1
Wenzhou 1
Xian 1
Totale 2.071
Nome #
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients 257
Modulation of Regulatory T-cell Subsets in Very Long-term Treated Aviremic HIV(+) Patients and Untreated Viremic patients 196
B-and T-lymphocyte number and function in HIV+/HIV- lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation 174
Long-Lasting production of New T and B Cells and T-Cell Repertoire Diversity in Patients with Primary Immunodeficiency Who Had Undergone Stem Cell Transplantation : A Single-Centre Experience 136
7-Hydroxymatairesinol improves body weight, fat and sugar metabolism in C57BJ/6 mice on a high-fat diet 129
T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects : review of the literature and future challenges 116
Modulation of IFNAR1 mRNA expression in multiple sclerosis patients 102
Interferon.Beta Therapy Monitoring in multiple sclerosis patients 95
Immune Defects of B- and T-Cell Compartments in Natalizumab-Induced Progressive Multifocal Leukoencephalopathy 95
Cutaneous infiltration of plasmacytoid dendritic cells and T regulatory cells in skin lesions of polymorphic light eruption 93
Thymic and bone marrow output in patients with common variable immunodeficiency 92
Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies 92
Adult-type hypolactasia genotyping in Northern Italy prevalence of C/T-13910 polimorphism and questions after comparison with existing data 89
Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients 87
The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency 86
Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients 83
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon beta therapy 82
Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy 72
Increase of IFNAR1 Messanger RNA in Myxovirus-protein-A-induced Multiple Sclerosis Patients to Oppose Loss of Protein Receptor 67
Opposite effects of interferon-beta on new B and T cells release from production sites in multiple sclerosis patients 60
Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19 59
IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays. 57
Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs 57
Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk 56
Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during end after narrow-band UVb phototherapy 51
Valutazione dei livelli sierici di fattore di necrosi tumorale alfa in pazienti psoriasici trattati con fototerapia NB-UVB 51
Modulation of regulatory T-cell subsets in very long-term treated aviremic HIV+ patients and untreated viremic patients 47
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome 12
Autoantibodies to Interferons in Infectious Diseases 9
Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function 6
Totale 2.608
Categoria #
all - tutte 9.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020791 89 38 34 75 50 112 86 89 57 99 25 37
2020/2021492 9 54 9 89 26 58 14 59 56 48 40 30
2021/2022213 12 21 3 11 2 24 5 11 10 30 26 58
2022/2023269 34 10 7 14 33 71 0 29 50 1 7 13
2023/2024239 20 4 26 20 6 39 13 10 57 2 4 38
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.608